Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Citi 17th Annual BioPharma Conference September 8, 2022
August 29 2022 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that it will be participating in investor meetings at the
Citi 17th Annual BioPharma Conference at the Four Seasons Hotel in
Boston on September 8, 2022.
Meeting DetailsFor investors attending the
conference who wish to meet with the Intercept management team,
please reach out to Nareg Sagherian at Intercept to check the
team’s availability.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). For more information, please
visit www.interceptpharma.com or connect with the company
on Twitter and LinkedIn.
ContactFor more information about Intercept,
please contact:
Investor
inquiries: investors@interceptpharma.com Media
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024